“Quality of Life in Patients With Metastatic or Unresectable Melanoma: Is Monotherapy With Nivolumab Preferred Over Combination Therapy?”. 2024. Revista Médica De Trujillo 19 (3): 092-097. https://doi.org/10.17268/rmt.2024.v19i3.6141.